Biotech Consortium India Limited (BCIL)
was incorporated as a public limited company in 1990 under
the Indian Companies Act 1956. Promoted by the Department
of Biotechnology, Government of India, its core capital
has been contributed mainly by the All India Financial Institutions
including IDBI, ICICI, IFCI, UTI and IFCI Venture Capital
Funds Limited (formerly RCTC) and the corporate sector including
Ranbaxy Laboratories, Glaxo India, Cadila Laboratories,
Lupin Laboratories, Kothari Sugars and Chemicals, Rallis
India, SPIC, Madras Refineries, Zuari Agro, EID Parry, ACC
and Excel Industries.
BCIL is engaged in technology transfer, project consultancy,
fund syndication, information dissemination and manpower
training and placement related to biotechnology. For technology
transfer, BCIL acts as an interface between technology sources
and technology seekers. The main sources of technologies
have been the universities and national laboratories where
research and development projects have been funded by the
DBT. Promising commercial leads are identified and developed
into technology packages in close interaction with the scientists.
The processes are then demonstrated to a select cross section
of industries to ascertain their interest following which
commercial negotiations for technology transfer are taken
up and concluded. Subsequently, BCIL continues interaction
with both the industries and the scientists so that any
gaps in the technology are bridged effectively. The projects
are monitored to ensure their timely implementation as per
the terms of technology transfer agreements.
BCIL also organizes Entrepreneurs' Meets and 'Sensitization
programmes' to create large scale awareness about the commercial
potential of the indigenously developed biotechnologies.
Representatives from government and financial institutions
are also invited in such meets to facilitate financial,
regulatory and other support to the entrepreneurs for expeditious
commercialization.
Wherever required, BCIL offers consultancy in the form
of market assessment, preparation of business plans or detailed
project reports to assist the industry and the entrepreneurs.
As on date, BCIL has assisted over 150 clients including
research institutions, industry, entrepreneurs, government,
financial institutions and international agencies.
Through its publications and the biotechnology club, BCIL
disseminates information relevant to commercial biotechnology
to industries, institutions, universities and entrepreneurs.
It also operates a biotech industrial training and placement
programme. Over 300 trainees have been trained and placed
in industry during the last five years.
BCIL WINS NATIONAL AWARD
Biotech Consortium India Limited (BCIL) has been
conferred a special award for "Biotech Product and
Process Development and Commercialization" for the
year 2001 instituted by the Department of Biotechnology,
Govt. of India, for its outstanding contribution in the
area of technology transfer.
Dr. S. R. Nair, Managing Director, BCIL received the award
from the Former Vice President of India, Shri Krishna Kant
on Technology Day, May 11, 2001.